VA

Vaso CorpOOTC VASO Stock Report

Last reporting period 30 Jun, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

0.032

Micro

Exchange

OOTC - OTC

VASO Stock Analysis

VA

Neutral

Based on Eyestock quantitative analysis, VASO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

53/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-66.8 %

Overvalued

Market cap $B

0.032

Dividend yield

Shares outstanding

175.13 B

Vaso Corporation is principally engaged in operating healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service and Equipment. The IT segment operates through the Company's subsidiary, VasoTechnology, Inc., which is focused on healthcare IT and managed network technology service. The Professional sales service segment operates through the Company's subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, which is focused on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. The Equipment segment is focused on designing, manufacturing, selling and servicing of medical devices, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.

View Section: Eyestock Rating